(Q46425065)

English

In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells

scientific article published in May 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

6

object named as

Tadeusz Robak

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

Piotr Smolewski

7

object named as

Piotr Smolewski

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

author name string

Markus Duechler

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

Anna Linke

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

Barbara Cebula

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

Medhat Shehata

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

Josef D Schwarzmeier

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

74

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

407-417

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

A field guide to ubiquitylation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Proteasome inhibition in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Nuclear factor-kappaB mediates up-regulation of cathepsin B by doxorubicin in tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00406.X

21 January 2018

Identifiers

10.1111/J.1600-0609.2004.00406.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15813915

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46425065&oldid=2111040663"